Myeloid malignancies like AML, MDS, and CML generally showed higher TGFB1 expression when compared to normal samples and the opposite was seen in lymphoid leukemias (ALL and CLL) (Fig. 2A). The gene discussed is TGFB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.